GENEVA, Aug. 17 -- REMEGEN CO., LTD. (No. 58 Beijing Middle Road, Yantai Development Zone, Yantai District, China (Shandong) Pilot Free Trade ZoneYantai, Shandong 264006), 荣昌生物制药（烟台）股份有限公司 (中国山东省烟台市中国（山东）自由贸易试验区烟台片区烟台开发区北京中路58号) filed a patent application (PCT/CN2025/074508) for "METHOD FOR TREATING CANCER WITH ANTI-MESOTHELIN ANTIBODY-DRUG CONJUGATE" on Jan 24, 2025. With publication no. W...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.
